5Deborah JT,Sarah HH, Russell EG. The summary of diabetes self-care activities measure. Diabetes Care,2000,23 (7): 943-950.
6HUSSAIN A, CLAUSSEN B, RAMACHANDRAN A. et al. Prevention of type 2 diabetes : A review [ J ]. Diabetes Res Clin Prac,2007,76930 (3) :317-326.
7LINNEBJER G H, KOTHARE P A,PARK S, et al. Effect of renal impairment on the pharmacokinetics of exenatide [ J]. Br J Clin Pharmacol,2007,64(3) :317-327.
8ROUBICEK T, MRA Z M, BARTLOVA M, et al. The influ- ence of 6-months treatment with exenatide on type 2 diabetes mellitus compensation , anthropometric and biochemical parameters [ J]. Vnitr Lek, 2010,56 ( 1 ) : 15- 20.
9VILSBOLL T. Liraglutide:a once-daily GLP-1 analogue for the treatment of type 2 diabetes mellitus [ J ]. Expert Opin Investig Drugs,2007,16 (2) :231-237.
10Yang W,Lu J,Weng J. Prevalence of diabetes among men and women in China[J].{H}New England Journal of Medicine,2010.1090-1101.